Gascón P - Search Results

1

Correction to: Epoetin Biosimilars in the Treatment of Chemotherapy-Induced Anemia: 10 Years' Experience Gained.

Aapro M, Krendyukov A, Schiestl M, Gascón P. Aapro M, et al. Among authors: gascon p. BioDrugs. 2018 Apr;32(2):137-138. doi: 10.1007/s40259-018-0268-3. BioDrugs. 2018. PMID: 29492906 Free PMC article.

2

Epoetin Biosimilars in the Treatment of Chemotherapy-Induced Anemia: 10 Years' Experience Gained.

Aapro M, Krendyukov A, Schiestl M, Gascón P. Aapro M, et al. Among authors: gascon p. BioDrugs. 2018 Apr;32(2):129-135. doi: 10.1007/s40259-018-0262-9. BioDrugs. 2018. PMID: 29417431 Free PMC article. Review.

3

Extrapolation in Practice: Lessons from 10 Years with Biosimilar Filgrastim.

Gascon P, Krendyukov A, Mathieson N, Natek M, Aapro M. Gascon P, et al. BioDrugs. 2019 Dec;33(6):635-645. doi: 10.1007/s40259-019-00373-2. BioDrugs. 2019. PMID: 31440986 Free PMC article. Review.

4

MONITOR-GCSF DLBCL subanalysis: Treatment patterns/outcomes with biosimilar filgrastim for chemotherapy-induced/febrile neutropenia prophylaxis.

Gascón P, Krendyukov A, Höbel N, Aapro M. Gascón P, et al. Eur J Haematol. 2018 Mar;100(3):241-246. doi: 10.1111/ejh.13002. Epub 2017 Dec 29. Eur J Haematol. 2018. PMID: 29171913

5

Development and 10-year history of a biosimilar: the example of Binocrit^®.

Aapro M, Krendyukov A, Höbel N, Seidl A, Gascón P. Aapro M, et al. Among authors: gascon p. Ther Adv Med Oncol. 2018 Apr 17;10:1758835918768419. doi: 10.1177/1758835918768419. eCollection 2018. Ther Adv Med Oncol. 2018. PMID: 29707043 Free PMC article. Review.

6

Treatment patterns and outcomes in patients with non-small cell lung cancer receiving biosimilar filgrastim for prophylaxis of chemotherapy-induced/febrile neutropaenia: Results from the MONITOR-GCSF study.

Aapro M, Krendyukov A, Höbel N, Gascon P. Aapro M, et al. Among authors: gascon p. Eur J Cancer Care (Engl). 2019 Jul;28(4):e13034. doi: 10.1111/ecc.13034. Epub 2019 Apr 10. Eur J Cancer Care (Engl). 2019. PMID: 30968997 Free PMC article.

7

Epoetin alfa for the treatment of myelodysplastic syndrome-related anemia: A review of clinical data, clinical guidelines, and treatment protocols.

Gascón P, Krendyukov A, Mathieson N, Aapro M. Gascón P, et al. Leuk Res. 2019 Jun;81:35-42. doi: 10.1016/j.leukres.2019.03.006. Epub 2019 Mar 27. Leuk Res. 2019. PMID: 31005849 Free article. Review.

8

Biosimilar Pegfilgrastim: Improving Access and Optimising Practice to Supportive Care that Enables Cure.

Cornes P, Gascon P, Vulto AG, Aapro M. Cornes P, et al. Among authors: gascon p. BioDrugs. 2020 Jun;34(3):255-263. doi: 10.1007/s40259-020-00411-4. BioDrugs. 2020. PMID: 32232676 Free PMC article. Review.

9

Chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim in elderly versus non-elderly cancer patients: Patterns, outcomes, and determinants (MONITOR-GCSF study).

Aapro M, Bokemeyer C, Ludwig H, Gascón P, Boccadoro M, Denhaerynck K, Gorray M, Krendyukov A, MacDonald K, Abraham I. Aapro M, et al. Among authors: gascon p. J Geriatr Oncol. 2017 Mar;8(2):86-95. doi: 10.1016/j.jgo.2016.09.006. Epub 2016 Nov 6. J Geriatr Oncol. 2017. PMID: 27829539 Free article.

10

Over- and under-prophylaxis for chemotherapy-induced (febrile) neutropenia relative to evidence-based guidelines is associated with differences in outcomes: findings from the MONITOR-GCSF study.

Bokemeyer C, Gascón P, Aapro M, Ludwig H, Boccadoro M, Denhaerynck K, Gorray M, Krendyukov A, Abraham I, MacDonald K. Bokemeyer C, et al. Among authors: gascon p. Support Care Cancer. 2017 Jun;25(6):1819-1828. doi: 10.1007/s00520-017-3572-4. Epub 2017 Jan 22. Support Care Cancer. 2017. PMID: 28111718 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

316 results

Search Page